Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Pankaj Bharali has a total of 89 co-authors. Here are the top co-authors by number of shared publications:

  • Bipankar Hajong

    Department of Botany, Bholanath College (Autonomous), Dhubri-783324, Assam, India; Biological Science and Technology Division, CSIR-North East Institute of Science and Technology (CSIR-NEIST), Jorhat, Assam, India; Academy of Scientific and Innovative Research (AcSIR), Ghaziabad-201002, India

    12 shared publications
  • Gayatri Gogoi

    CSIR-North East Institute of Science and Technology

    6 shared publications
  • Aditya Sarkar

    4 shared publications
  • Akib Ali

    Botany Department, North Eastern Hill University, Shillong, India

    4 shared publications
  • Bipankar Hajong

    Department of Botany, Bholanath College (Autonomous), Dhubri Assam India

    4 shared publications
  • Devpratim Koch

    Biological Science and Technology Division, CSIR‐North East Institute of Science and Technology (CSIR‐NEIST), Jorhat Assam India

    4 shared publications

Latest Publications

  • Allium beesianum (Amaryllidaceae): A New Record for the Flora of India

    by Bipankar Hajong, Sambit Chowdhury, Anurag Paul, Pankaj Bharali

    Allium beesianum W.W.Sm. (Amaryllidaceae), a native of Southern China has been collected from Tawang district of Arunachal, India in 2025 is reported here as an addition to the Flora of India. Morphological description, distribution map and a photo plate were provided here for its proper recognition.

  • Begonia mishmiorum (Sect. Platycentrum), a remarkable new species from the Mishmi Hills of Arunachal Pradesh, India

    by Sambit Chowdhury, Bipankar Hajong, Pankaj Bharali

    A remarkable new species, Begonia mishmiorum sp. nov. (sect. Platycentrum), from Anjaw district of Arunachal Pradesh, India, is described and illustrated. The species is allied to Begonia persistens Y.H.Tan, M.B.Maw & H.B.Ding and Begonia dicressine Wahlsteen but is readily distinguished by a unique combination of characters, notably its conspicuous, persistent bracteoles that are pinkish-white, deltoid to broadly ovate, sparsely hairy, and completely enclosing the ovary, a feature rarely observed within the section. It further differs in having glabrous, terete petioles, asymmetric cordate leaves with a variegated adaxial surface. A detailed taxonomic description, colour photographs, and a comparison table with allied species are provided. The species is currently known only from a single locality Mithumna in Anjaw district, where its habitat is fragmented and declining due to road construction and landslides. Owing to insufficient data on its population size and distribution, it is provisionally assessed as Data Deficient (DD) following IUCN criteria. Further field studies are needed to clarify its conservation status.

  • Untreated Surface Water as a Reservoir of Public Health Threats: A One Health Study from Northeast India

    by Gayatri Gogoi, Sachin B. Jorvekar, Roshan M. Borkar, Himakshi Sarma, Pankaj Bharali, Hridoy Jyoti Mahanta, Virendra M. Tiwari

  • Open Access

    Primula himalayana sp. nov., a new species from eastern Himalaya, India

    by Bipankar Hajong, Harsh Singh, Pankaj Bharali

    Primula himalayana sp. nov., a new species of Primulaceae, is described and illustrated from Tawang, Lutrem, 4238 m a.s.l., Arunachal Pradesh, India. It grows under Juniperus and Berberis scrub forest in an alpine meadow. The new species belong in Primula section Cordifoliae and is resembling P . gambeliana , but differs from the latter by the lamina puberulent with a white protuberance on the tips of the teeth, petiole 2‒3 times longer than lamina and white puberulent, scape long with many flowers, flowers yellow with orange‐yellow center and along corolla tube, corolla lobes elliptic, anther basifixed, and ovary cylindrical without any teeth.

  • Open Access

    Three new deciduous species of Berberis (Berberidaceae) from Tawang and West Kameng, Arunachal Pradesh, India

    by Bipankar Hajong, Julian Harber, Pankaj Bharali

    Based on morphological evidence three new deciduous species of Berberis are proposed – Berberis pseudovirescens , Berberis orbicularis and Berberis tawangensis ,the types being collected in the Tawang and West Kameng districts of Arunachal Pradesh, India. Detailed descriptions and diagnoses, along with colour photoplates, distribution information and conservation status are provided. All these new species are provisionally evaluated as ‘Data Deficient' (DD) following IUCN guidelines.

  • Open Access

    Parakaempferia alba sp. nov. (Zingiberaceae), a new species from Arunachal Pradesh, India

    by Tatum Mibang, Bipankar Hajong, Devpratim Koch, Pankaj Bharali

    Parakaempferia alba, a new species of Zingiberaceae from East Siang district of Arunachal Pradesh, India is herein described. A detailed taxonomic description, diagnosis, color photoplate, distribution map, notes on habitat and ecology, conservation status, and a table of comparisons with the closely related species Parakaempferai synantha Rao & Verma are provided. This new species differs, inter alia, from P. synantha by its leaf characters, number of spikes, length of peduncle, number of bracts as well as their shape and size, bracteole shape and size, staminode shape and color, labellum shape and color of apical margin, anther size and color, filament size, style size, ovary shape, and by presence of two linear shaped glands attached to the ovary.

  • Biomarker driven drug repurposing for Fuchs’ endothelial corneal dystrophy (FECD): a computational study

    by Sarangthem Dinamani Singh, Gayatri Gogoi, Selvaraman Nagamani, Pankaj Bharali

    Fuchs’ Endothelial Corneal Dystrophy (FECD) is a slowly advancing, non-inflammatory eye condition due to a gradual increase in the thickness of the Descemet’s membrane and the gradual decline in the corneal endothelial cell population. It can occur sporadically or be inherited in an autosomal dominant manner, leading to impaired vision over time. Corneal transplantation is currently the only treatment for FECD. This study aims to identify potential biomarkers, pathways, and therapeutic targets to treat FECD. The dataset GSE171830 was retrieved from Gene Expression Omnibus (GEO) database for the purpose of investigating and identifying potential therapeutic targets for FECD. Using the GEO2R tool, 2654 differentially expressed genes (DEGs) were identified, with 1763 upregulated and 881 downregulated genes, for annotating FECD pathogenesis pathways. We conducted gene enrichment analysis with the aim of identifying the pathways associated with FECD disease. Selected DEGs functional annotations show the involvement of several FECD-related biological processes and pathways. Our findings unravel potential biomarkers, including HLA-DRA, CSF1R, TNFRSF11B, COL4A1, etc., through GO, KEGG analysis, and Protein–Protein Interaction (PPI). Among them, we considered two targets, viz. CSF1R, TNFRSF11B due to their small molecule binding pockets. Further, virtual screening was performed against 61 FDA-approved eye care drugs, and we identified the top five drugs for each target, and the results are discussed in detail. The findings from this study could offer novel insights into the molecular mechanism of FECD, and the identified drugs could have a significant impact on the treatment and prevention of FECD. Graphical abstract


  • Non-Peptidic Anti-Aggregate Compounds

    by Akib Ali, Babita Kumari, Pankaj Bharali

    The persistent challenge of developing effective treatments for Alzheimer's disease (AD) has led researchers to explore various therapeutic approaches. Among these, non-peptidic anti-aggregate compounds have emerged as particularly promising candidates due to their potential to prevent the formation of toxic amyloid aggregates while offering advantages in stability, bioavailability, reduced immunogenicity, and better pharmacokinetic properties over peptide-based alternatives. These compounds encompass diverse categories, including small molecules, metal chelators, molecular chaperones, and allosteric modulators, each with unique mechanisms to inhibit, disaggregate, or prevent the formation of amyloid-β (Aβ) and tau aggregates that cause neural disfunction. Although recent advancements in Alzheimer's research have highlighted the therapeutic potential of natural products such as rutin, curcumin, and resveratrol, along with synthetic agents like tramiprosate and innovative chemical chaperones, challenges such as ensuring specificity, minimizing off-target effects, and demonstrating long-term safety remain critical. This review therefore enumerates the current progress, mechanisms, and future prospects of non-peptidic anti-aggregate compounds, emphasizing their role in addressing the unmet clinical needs of AD therapy. The role of nanotechnology and artificial intelligence (AI)/machine learning (ML) in AD therapy is also briefly highlighted. With continued research and innovation, these compounds could pave the way for more effective and accessible treatments for this debilitating disease.